| Literature DB >> 35571450 |
Xianben Liu1, Kun Gao1, Wenqun Xing1, Zongfei Wang1, Haibo Sun1, Yan Zheng1.
Abstract
Background: Esophageal cancer in China accounts for nearly half of the global esophageal cancer cases. The relationship between the occurrence of postoperative complications of esophageal cancer surgery and seasonal changes is not clear. Our purpose is to clarify the relationship between postoperative complications of esophageal cancer and season, so as to reduce the incidence of complications.Entities:
Keywords: Esophageal cancer; postoperative complications; season
Year: 2022 PMID: 35571450 PMCID: PMC9096384 DOI: 10.21037/atm-21-5050
Source DB: PubMed Journal: Ann Transl Med ISSN: 2305-5839
Baseline demographic and clinical characteristics of patients
| Characteristic | Summer group (n=138) | Non-summer group (n=113) | P |
|---|---|---|---|
| Age (years) | 62 [57–68] | 62 [57–67] | 0.783 |
| Sex | 0.077 | ||
| Male | 95 (68.8%) | 89 (78.8%) | |
| Female | 43 (31.2%) | 24 (21.2%) | |
| Smoking (yes) | 66 (47.8%) | 70 (61.9%) | 0.025 |
| Diabetes (yes) | 8 (5.8%) | 9 (8.0%) | 0.497 |
| Location of tumor | 0.643† | ||
| Neck | 2 (1.4%) | 1 (0.9%) | |
| Upper | 25 (18.1%) | 14 (12.8%) | |
| Middle | 55 (39.9%) | 50 (45.9%) | |
| Lower | 56 (40.6%) | 44 (40.4%) | |
| NCT | 34 (24.6%) | 38 (33.6%) | 0.117 |
| Operation time (min) | 220 [180–240] | 220 [187–255] | 0.293 |
| Postoperative hospital stay (day) | 14 [9–21] | 14 [10–21] | 0.584 |
| Blood loss in mL | 50 [50–112] | 80 [30–115] | 0.913 |
| Lymphadenectomy | 0.550† | ||
| 2-Field | 133 (96.4%) | 107 (94.7%) | |
| 3-Field | 5 (3.6%) | 6 (5.3%) | |
| No. of harvested lymph nodes | 15 [11–19] | 18 [15–24] | <0.001 |
| Histology | 0.285† | ||
| Squamous cell carcinoma | 112 (81.2%) | 95 (84.1%) | |
| Adenocarcinoma | 1 (0.7%) | 1 (0.9%) | |
| Adenosquamous carcinoma | 17 (12.3%) | 7 (6.2%) | |
| Other | 8 (5.8%) | 10 (8.8%) | |
| pTNM staging 7th | 0.250 | ||
| pCR | 5 (3.6%) | 8 (7.1%) | |
| I | 22 (15.9%) | 23 (20.4%) | |
| II | 73 (52.9%) | 51 (45.1%) | |
| III | 38 (27.5%) | 29 (25.7%) | |
| IV | 0 | 2 (1.8%) |
†, Fisher’s exact test. NCT, neoadjuvant chemotherapy; pCR, pathological complete response.
Details of postoperative complications in the two groups
| Variable | Summer group (n=138) | Non-summer group (n=113) | P | Difference (95% CI) |
|---|---|---|---|---|
| Respiratory complications (total) | 23 (16.7%) | 31 (27.4%) | 0.039 | 10.77% (0.45–21.08%) |
| Pneumonia | 11 (8.0%) | 21 (18.6%) | 0.012 | 10.61% (2.14–19.09%) |
| Atelectasis | 2 (1.4%) | 9 (8.0%) | 0.025† | 6.52% (1.14–11.89%) |
| Pleural effusions | 4 (2.9%) | 5 (4.4%) | 0.735† | 1.53% (−3.19–6.24%) |
| Pneumothorax | 2 (1.4%) | 3 (2.7%) | 0.660† | 1.21% (−2.37–4.78%) |
| Mediastinitis | 2 (1.4%) | 3 (2.7%) | 0.660† | 1.21% (−2.37–4.78%) |
| Respiratory failure | 1 (0.7%) | 4 (3.5%) | 0.178† | 2.82% (−0.87–6.50%) |
| Cardiac complications (total) | 11 (8.0%) | 19 (16.8%) | 0.032 | 8.84% (0.60–17.09%) |
| Myocardial arrhythmia | 9 (6.5%) | 17 (15.0%) | 0.027 | 8.52% (0.75–16.30%) |
| Heart failure | 2 (1.4%) | 2 (1.8%) | 1† | 0.32% (−2.82–3.46%) |
| Gastrointestinal complications (total) | 11 (8.0%) | 9 (8.0%) | 0.999 | −0.01% (−6.74–6.73%) |
| Anastomotic leak | 10 (7.2%) | 7 (6.2%) | 0.741 | −1.05% (−7.25–5.15%) |
| Peritoneal effusion | 1 (0.7%) | 0 | 1† | −0.72% (−2.14–0.69%) |
| Delayed gastric emptying | 0 | 2 (1.8%) | 0.202 | 1.77% (−0.66–4.20%) |
| Incision complication | 14 (10.1%) | 4 (3.5%) | 0.044 | −6.61% (−12.69% to −0.52%) |
| Wound infection | 3 (2.2%) | 2 (1.8%) | 1† | −0.40% (−3.84–3.04%) |
| Fat necrosis | 11 (8.0%) | 2 (1.8%) | 0.027 | −6.20% (−11.33% to −1.07%) |
| Unilateral RLN injury | 23 (16.7%) | 12 (10.6%) | 0.169 | −6.05% (−14.47–2.37%) |
| Deep venous thrombosis | 1 (0.7%) | 2 (1.8%) | 0.590 | 1.05% (−1.77–3.86%) |
| Chylothorax | 1 (0.7%) | 2 (1.8%) | 0.590 | 1.05% (−1.77–3.86%) |
| Bacteremia | 6 (4.3%) | 2 (1.8%) | 0.301 | −2.58% (−6.76–1.60%) |
| In-hospital mortality | 0 | 0 | NA | NA |
†, Fisher’s exact test. RLN, recurrent laryngeal nerve; NA, not available; CI, confidence interval.